Published Online: March 30, 2015. doi:10.1001/jama.2015.2912.
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Benzon reported that he is the deputy editor in chief of Pain Practice, and is a member of the board of directors of the American Society of Regional Anesthesia and Pain Medicine. Dr Huntoon reported that he is the editor in chief of Regional Anesthesia and Pain Medicine, a director of the North American Neuromodulation Society and has been a member of the board of directors of the American Society of Regional Anesthesia and Pain Medicine. Dr Rathmell reported that he is the executive editor of Anesthesiology and a director of the American Board of Anesthesiology.
Additional Contributions: We thank Salma Lemtouni, MD, MPH, of the FDA Safe Use Initiative for indefatigably coordinating the teleconferences of the working group; representatives of the national organizations; John Whyte, MD, chief of the FDA Safe Use Initiative for his review and revisions on the involvement of the FDA; and Laurie Haughey, Professional Affairs & Stakeholder Engagement of the FDA, for her review and revisions on the involvement of the FDA, providing the latest official statement of FDA and the URL to the official report of the FDA Advisory meeting.